Jbm (Healthcare) Ltd
HKEX:2161
Jbm (Healthcare) Ltd
Operating Income
Jbm (Healthcare) Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Jbm (Healthcare) Ltd
HKEX:2161
|
Operating Income
HK$70.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Operating Income
¥3.2B
|
CAGR 3-Years
36%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Operating Income
¥6.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Operating Income
¥1.4B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
19%
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Operating Income
HK$12.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
HUTCHMED (China) Ltd
LSE:HCM
|
Operating Income
$18.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Jbm (Healthcare) Ltd's Operating Income?
Operating Income
70.5m
HKD
Based on the financial report for Mar 31, 2023, Jbm (Healthcare) Ltd's Operating Income amounts to 70.5m HKD.
What is Jbm (Healthcare) Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
6%
Over the last year, the Operating Income growth was 82%. The average annual Operating Income growth rates for Jbm (Healthcare) Ltd have been 10% over the past three years , 6% over the past five years .